Autophagic factors in Paget disease

Pathol Res Pract. 2022 Aug:236:154001. doi: 10.1016/j.prp.2022.154001. Epub 2022 Jun 30.

Abstract

Background: Despite autophagy being a principal mechanism of tumor progression, its role has been never studied in Paget disease, a difficult to treat intraepithelial neoplasia affecting mainly the breast and the vulvar regions.

Material and methods: Twenty seven cases (17 extramammary and 10 mammary) of Paget disease were immunohistochemically studied for the expression of the two principal autophagic factors, LC3B and p62.

Results: The majority of Paget diseases showed strong cytoplasmic expression of p62 in contrast to nearby keratinocytes which presented nuclear-only p62 staining. LC3B was negative or only mildly positive in neoplastic cells. No difference was seen between mammary and extramammary cases.

Conclusion: The immunohistochemical autophagic profile of Paget disease suggests a down-regulated autophagic process which, thus, may be implicated in the invasive potential of these cells.

Keywords: Adenocarcinoma; Autophagy; In situ; LC3B; Mammary; P62; Vulvar.

MeSH terms

  • Adenocarcinoma* / metabolism
  • Autophagy
  • Biomarkers, Tumor / metabolism
  • Female
  • Humans
  • Paget Disease, Extramammary* / metabolism
  • Paget Disease, Extramammary* / pathology
  • Vulvar Neoplasms* / pathology

Substances

  • Biomarkers, Tumor